Latest Breaking News On - Lilly asia ventures - Page 1 : comparemela.com

Kumquat Lands $130M Takeda Deal - San Diego Business Journal

Kumquat Lands $130M Takeda Deal - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesYi liuGenomics institute of the novartis research foundationSequoia capitalRoche venture fundTakeda pharmaceuticalsKumquat bioOncology therapeutic area unitLilly asia venturesSorrento valleyWellspring biosciencesKura oncologyGenomics instituteNovartis research

Chinese biopharma firm IMPACT closes $55m Series D+ round to advance cancer drugs

The Series D+ round was led by GTJA Investment Group and Beijing-based state capital investor Kingray Capital.

Leiwen chenJunshi biosciencesNational medical products administrationYangzhou guojin groupInvestment groupDrug administrationYangzhou cityLilly asia venturesNew drug applicationKingray capitalEikon therapeuticsHong kong listedWuxi apptecCenova venturesDecheng capital

ProfoundBio Discovers The Joys Of Having A Wealthy Owner (NASDAQ:GMAB)

ProfoundBio Discovers The Joys Of Having A Wealthy Owner (NASDAQ:GMAB)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited kingdomZhao baitengArrivent biopharmaNuvation bio incUniversity of texasProfoundbio incDrug administrationAnheart therapeutics ltdGracell biotechnologiesEastern chinesePeking universityLilly asia venturesEli lillySanreno therapeuticsNuvation bio

Santhera Pharmaceuticals Holding AG: Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China s NMPA

Santhera Pharmaceuticals Holding AG: Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China s NMPA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalNorth lanarkshireUnited kingdomEva kaliasDennis riedlBreakthrough therapy programHead investor relations communicationsChina national medical products administrationSanthera pharmaceuticalsEuropean unionSanthera pharmaceuticals holdingSperogenix therapeuticsDrug evaluationLilly asia venturesMorningside venturesHead investor relations

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China s NMPA

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China s NMPA
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

North lanarkshireUnited kingdomSwitzerland generalUnited statesEva kaliasSanthera pharmaceuticals holdingChina national medical products administrationRegulatory agencySanthera pharmaceuticalsAmerica to catalyst pharmaceuticals incEuropean union summary of product characteristicsBreakthrough therapy programHead investor relations communicationsDrug administrationLife science allianceEuropean medicines agency